|
?:authorAffiliation
|
-
[\'Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden hannah.bower@ki.se.\', \'Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Public Health and Clinical Medicine/Rheumatology, Umeå Universitet, Umeå, Sweden.\', \'Unit of Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.\', \'Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.\', \'Swedish Medical Products Agency, Uppsala, Sweden.\', \'Department of Public Health and Caring Sciences, Uppsala Universitet, Uppsala, Sweden.\', \'Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.\', \'Department of Biomedical and Clinical Sciences, Linkopings Universitet, Linkoping, Sweden.\', \'Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden.\', \'Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden.\', \'Department of Biomedical and Clinical Sciences, Linköping University, Linkoping, Sweden.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}